Initial OnKure Therapeutics, Inc. data from PIKture-01 study on OKI-219 for PI3Ka-H1047R breast cancer expected in Q4, 2024.

Unusual variations in the cellular protein factory can skew development, help cancer spread and more. But ribosome variety ...

Researchers from The University of Texas MD Anderson Cancer Center demonstrated that anti-PD-L1 immunotherapy in combination ...

Americans once made their own costumes and candy. Now, the holiday has rapidly commercialized, transforming into an economic ...

Researchers at University of Michigan have identified a rare genetic mutation that increases the likelihood of babies being ...

Research led by The University of Texas Health Science Center at San Antonio (UT Health San Antonio) and the University of Chicago is the first to explain the pathway of the enzymatic activity of the ...

For some proteins, a single mutation, or change in its DNA instructions, is all it takes to tip the balance between ...

By creating personalized brain 'organoids' in the lab, scientists showed how microRNAs impact brain development, and demonstrate how one drug can reverse critical cellular signs of autism.

The study also didn’t test female flies. If the driving X chromosome is what directly increases aggression, it might impact ...

CHICAGO -- A mutation-agnostic gene therapy for retinitis pigmentosa (RP) showed promise for improving vision in severely ...

The Bcl-2 inhibitor venetoclax is highly effective and is another first- or second-line option even if this agent, like BTK inhibitors, also appears to require continuous dosing, said Stadtmauer, ...